MetLife, Inc. filings document the regulatory record of a Delaware financial services company with NYSE-listed common stock and preferred securities, including depositary shares tied to Series E and Series F preferred stock. Recent Form 8-K reports furnish earnings releases, quarterly financial supplements, total assets under management fact sheets and Regulation FD disclosures related to variable investment income.
The filings also cover capital-structure actions such as subordinated debenture issuance and preferred stock dividend declarations. Proxy materials describe board composition, committee assignments, executive compensation and shareholder voting matters, while material-event reports record governance changes and other corporate disclosures.
MetLife Inc director Laura J. Hay acquired 40 shares of common stock on March 10, 2026 at $70.60 per share. The filing describes this as a grant or award, specifically an imputed reinvestment of dividends on deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors.
Following this transaction, Hay directly holds 4,971 shares of MetLife common stock. The deferred shares have become payable, but she has chosen to defer actual receipt of the shares.
MetLife Inc. director William E. Kennard acquired additional common stock through a compensation-related award. On 2026-03-10, he received 365 shares of MetLife common stock at $70.60 per share, reflecting imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
After this award, Kennard directly holds 45,780 MetLife common shares. He also has an additional 10 shares held indirectly through the MetLife Policyholder Trust, which was established to hold stock allocated to eligible policyholders. These transactions are non-open-market and arise from director compensation and trust holdings rather than discretionary buying or selling.
MetLife director Christian Stephane Mumenthaler acquired 17 shares of common stock as a grant under the MetLife Deferred Compensation Plan for Non-Management Directors. The award, recorded at a reference price of $70.60 per share, brings his directly held MetLife shares to 2,125.
MetLife Inc director Carla A. Harris reported acquiring 43 shares of common stock on March 10, 2026 at $70.60 per share. The filing explains this was an imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
After this award, Harris directly holds 9,764 MetLife common shares. The transaction reflects compensation-related dividend reinvestment rather than an open-market stock purchase.
MetLife, Inc. filed a report confirming a previously announced first quarter 2026 dividend on its floating rate non-cumulative preferred stock, Series A. The dividend is $0.31501229 per share on shares with a $25 liquidation preference.
The company stated that the dividend will be payable on March 16, 2026, to shareholders of record as of Friday, February 27, 2026, because the normal record date of March 1, 2026 falls on a Sunday. The New York Stock Exchange had not yet set an ex-dividend date for the Series A preferred stock at the time of the announcement and is expected to set it following this confirmatory announcement.
MetLife Inc. executive John D. McCallion reported a tax-related share disposition. On March 2, 2026, 6,985 shares of MetLife common stock were withheld at $73.24 per share to cover taxes on vested restricted stock units. After this non-market transaction, he directly owned 275,194 shares.
MetLife Inc executive Shurawl Sibblies, EVP & Chief HR Officer, reported a tax-withholding disposition related to restricted stock units. On March 2, 2026, 220 shares of common stock were withheld at $73.24 per share for taxes, leaving her with 28,036 directly owned shares.
MetLife Inc. executive Marlene Debel, EVP & Chief Risk Officer, reported a tax-related share disposition. On the reported date, 4,133 shares of MetLife common stock were withheld to cover taxes on shares issued from restricted stock units. After this withholding, she directly held 154,380 shares.
MetLife Inc. President & CEO Michel Khalaf reported a tax-related share disposition tied to restricted stock units. On this Form 4, 22,420 shares of common stock were withheld at $73.24 per share to cover taxes, a non‑market transaction. After this withholding, he directly holds 697,709 shares of MetLife common stock.
MetLife executive Bill Pappas had 5,989 common shares withheld for taxes at $73.24 per share related to restricted stock units. After this tax-withholding disposition, he directly holds 83,746 common shares. He also reports indirect holdings of 10,220 shares in a 2024 GRAT and 18,750 shares in a 2025 GRAT.